2016
DOI: 10.14800/macrophage.1101
|View full text |Cite
|
Sign up to set email alerts
|

Macrophages are involved in cell-in-cell structures in human tumors

Abstract: Macrophage is a type of versatile cell and being developed as a therapeutic target for multiple diseases. Recent work showed that macrophages, specifically the CD163 + M2 cells, participated in the formation of cell-in-cell structures in human tumors, which may represent a novel mechanism for macrophages/phagocytes to influence tumor development and progression, and potentially help identify novel therapeutic targets for tumor treatment.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 24 publications
0
1
0
Order By: Relevance
“…Based on a set of molecular machinery [20][21][22][23][24][25][26][27], CICs could be formed homotypically (same type of cells) or heterotypically (different types of cells) between cells [28], leading to the death of the internalized cells [29,30] in an acidified lysosome [31]. CICs were most frequently documented in a variety of human tumor tissues [32][33][34][35], where CICs could promote clonal selection and tumor evolution as a mechanism of cell competition [1,36,37], or compromise tumor growth via mediating the in-cell killing by immune cells [38]. Accordingly, CICs and their subtypes had been shown to be an independent prognostic factor for cancer patients [39][40][41][42][43].…”
Section: Introductionmentioning
confidence: 99%
“…Based on a set of molecular machinery [20][21][22][23][24][25][26][27], CICs could be formed homotypically (same type of cells) or heterotypically (different types of cells) between cells [28], leading to the death of the internalized cells [29,30] in an acidified lysosome [31]. CICs were most frequently documented in a variety of human tumor tissues [32][33][34][35], where CICs could promote clonal selection and tumor evolution as a mechanism of cell competition [1,36,37], or compromise tumor growth via mediating the in-cell killing by immune cells [38]. Accordingly, CICs and their subtypes had been shown to be an independent prognostic factor for cancer patients [39][40][41][42][43].…”
Section: Introductionmentioning
confidence: 99%